41results about How to "Clear diagnosis" patented technology

The present invention relates to a gastrointestinal color ultrasonic contrast medium. It is a Chinese medicine preparation made up by using the Chinese medicinal materials of ark shell 2 portions, corydalis tuber 2 portions, pearl 1 portion, abalone shell, portion and cuttlefish bone 1 portion through the processes of selecting raw material, washing, drying, pulverizing to 100 meshes, uniformly mixing them, sterilizing, filling and capsulizing to obtain the invented finished procuct. The invention has no toxic side effect, can be used for accurately diagnosing various gastrointestinal diseases.

The invention discloses a turbo generator set vibration fault diagnosis method based on forward reasoning. After a diagnosed turbo generator set starts, a parameter detection device is employed to carry out real-time detection on related work parameters in a start and operation process of the diagnosed turbo generator set and synchronously sends the detection information to a vibration fault diagnosis device for automatic vibration fault diagnosis, vibration faults of the diagnosed turbo generator set are diagnosed level by level by the vibration fault diagnosis device according to the detection result transmitted by the parameter detection device in combination with the active power value of the diagnosed turbo generator set, and the fault diagnosis process comprises steps of 1, shaft vibration swinging value diagnosis; 2, start process vibration fault diagnosis; 3, zero load operation vibration fault diagnosis; and 4, loaded operation vibration fault diagnosis. The method is advantaged in that the steps are simple, and the method is reasonable in design, is convenient to realize, has good use effects, can conveniently and rapidly accomplish the online steam turbine vibration fault diagnosis process and can further realize accurate and reliable diagnosis results.

The invention discloses an anorectum checking and drug delivering device. The anorectum checking and drug delivering device comprises an outer cannula, an inner cannula, a drug deliverer and a biopsy device. The outer cannula and the inner cannula are both of a conical structure. The outer cannula comprises an inner layer and an outer layer. The outer layer covers the inner layer from the conical bottom face of the inner layer directly to the lower middle portion of the inner layer. The inner layer and the outer layer are connected only through a fixing end, a drug deliverer containing bin is arranged in the space between the inner layer and the outer layer, an annular drug deliverer inserting opening is formed in the bottom of the drug deliverer containing bin, and a drug delivery outlet is formed in the top of the drug deliverer containing bin. The drug deliverer is arranged in the drug deliverer containing bin and can move along the drug deliverer containing bin within the axial 360-degree range. A gap is reserved in the conical top end of the outer cannula and serves as an inner cannula extension opening, and the upper end of the inner cannula stretches out of the inner cannula extension opening. An opening is formed in the side face of the top of the inner cannula, the biopsy device is arranged in the inner cannula, and the sampling end of the biopsy device stretches out of the opening. The interior of the anorectum can be checked, sampled and subjected to drug delivery, and the anorectum checking and drug delivering device is simple in structure and convenient and rapid to use.

The invention relates to the field of the medical microecology, in particular to a new vaginal microecological evaluation system and a reagent kit used for measuring and evaluating the vaginal microecology; the vaginal microecological system of the invention comprises the evaluating items that: the intensity of flora, the diversity of flora, dominant bacterium and reason bacterium; by using the system of the invention, three vaginal inflammations of BV, VVC and trichomoniasis which are common in clinic can be diagnosed fast at one time, and the problem existed in the vaginal microenvironment of patients with vaginal inflammation can be found; the most important is that microecological evaluation can be carried out for the patients with vaginal inflammation which comprises symptoms of increasing leucorrhea and pruritus vulvue, etc. without special pathogenic bacteria in the current clinic and is hard to diagnose by the existing method, the clinic drug is guided and evaluation is prognosed, thus achieving the purpose of guiding the clinical treatment.

The invention discloses a cognitive training and recovery system based on a virtual reality technology. The cognitive training and recovery system comprises a login module, a task module, an animationmodule, a control module and a database. The login module is used for a preparation stage before task execution, parameter setting is carried out according to the control panel, scene switching is carried out after setting is completed, and save is used for storing in the control panel after switching is completed. The task module mainly comprises three functions of task generation, task result judgment and task result feedback; the animation module is divided into an animation setting part and an animation triggering part; and the control module is divided into a control triggering part, a control setting part and a control storage part. The database stores all the data into the database, meets addition, deletion and modification of different conditions, and exports each experiment result from the database into a log file. The system can help medical staff to record the conditions of the patient in the aspects of operation and cognition, and the conditions are improved through fixedtraining and questionnaire.

The invention discloses a gastrointestinal contrast agent containing traditional Chinese medicine ingredients. The gastrointestinal contrast agent consists of the following components in parts by weight: 55-75 parts of barium sulfate, 5-15 parts of a traditional Chinese medicine extract and 20 parts of mannitol, wherein the traditional Chinese medicine extract is prepared by a method comprising the following steps: mixing the following materials in parts by weight: 20-30 parts of bark of Chinese corktree, 10-20 parts of dried tangerine peel, 10-20 parts of coix seed, 5-10 parts of all-grass of hirsute gonostegia, 10-20 parts of tuckahoe, 20-30 parts of hawthorn, 5-15 parts of herb of christensen ceropegia, 20-30 parts of officinal magnolia bark, 10-20 parts of immature bitter orange, 20-30 parts of dwarf lilyturf tuber, 10-20 parts of Chinese angelica, 10-20 parts of turmeric root-tuber, 5-15 parts of Chinese caterpillar fungus and 10-20 parts of licorice; mixing; immerging by adding water; decocting; filtering; and drying. The gastrointestinal contrast agent disclosed by the invention can achieve beneficial effects of shortening the examination time, relieving side effects (nausea, emesis, inappetence and fatigue) caused by X-ray examination and the like, can also achieve an effect of nourishing or taking good care of stomach, liver and the like, and has a better using effect.

The invention discloses a reagent for detecting anti-platelet surface receptor-specific autoantibodies and a preparation method and application thereof. The reagent has high specificity and sensitivity. The method comprises expressing a human platelet-specific receptor membrane glycoprotein GP Ib-IX and/or GP IIb/IIIa receptor through CHO cells, carrying out co-incubation on the specific membraneglycoprotein receptor expression-positive CHO cells and serum to be detected and adding a fluorescein-labeled anti-human immunoglobulin polyclonal antibody (secondary antibody) for bonding. If there is an anti-platelet receptor-specific antibody in serum or plasma, the CHO-membrane glycoprotein specific antibody-fluorescein-labeled anti-human immunoglobulin polyclonal antibody complex structure isformed, has high CHO cell fluorescence intensity and can be used for flow cytometry or fluorescence microscope examination. The method is easy to operate, has enough specific membrane glycoprotein expression positive CHO cell sources, high specificity and sensitivity and high diagnosis efficiency and can be used for basic research and clinical examination.

The invention discloses an esophagus functional disease diagnosis system based on multi-mode information. The system comprises a multi-mode information acquisition system, and a computer with a multi-mode information pre-processing system, a multi-mode information fusion program and a conditional probability table. The multi-mode information acquisition system is used for acquiring multiple kindsof single-mode information. A single-mode information pre-processing unit corresponding to each kind of single-mode information acquired by the multi-mode information acquisition system is arranged inthe multi-mode information pre-processing system. The multi-mode information fusion program is used for calculating the multi-mode information fusion probability through a Bayes inference model according to the single-mode information and the conditional probability table and judging esophagus functional diseases according to the multi-mode information fusion probability. The technical problem that in the prior art, the diagnosis accuracy of diagnosing the esophagus functional diseases according to single-mode characteristics is not high is solved, the esophagus functional diseases are diagnosed through multi-mode information fusion, and the diagnosis accuracy can be improved.

The invention belongs to the field of molecular biological detection. Specifically, the invention belongs to the field of detection of pathogens causing respiratory tract infection; and more specifically, the present invention can simultaneously detect influenza A virus, influenza B virus, rhinovirus, respiratory adenovirus, respiratory syncytial virus, and mycoplasma pneumoniae. By using a composition provided by the invention, the six pathogens causing respiratory tract infection can be detected at the same time, and specific infection of one or more pathogens can be identified. Meanwhile, the detection rate is higher than that of the existing composition, and the detection is more accurate.

The invention discloses a fault diagnosis method of a water power set. Characteristic parameters of different fault vibration signals of the water power set are extracted to establish a fault set; a step factor and the discovery probability of Cuckoo search are embedded into an optimal solution searching process, a proper control parameter value is selected adaptively according to the quality of the solution, and the method is suitable for different optimization problems. A non-uniform variation operator is used to adjust the searching step of the present optimal solution adaptively, and the convergence precision of the algorithm is improved further. The adaptive Cuckoo search is used to find an optimal weight threshold parameter of the BP neural network, and a fault diagnosis model of thewater power set is established; and compared with a neural network model and a Cuckoo search neural network model, the method of the invention can be used to improve the fault positioning efficiencyand accuracy of the water power set substantially.

The invention discloses a medicinal preparation of a gastrointestinal color ultrasound contrast agent. The medicinal preparation is prepared from the following preparation raw materials in parts by weight: 20 to 30 parts of flos sophorae immaturus, 15 to 25 parts of fructus perillae, 10 to 20 parts of herba cistanches, 5 to 10 parts of calyx kaki, 5 to 10 parts of ruddle, 5 to 10 parts of halloysitum rubrum, 5 to 10 parts of radix linderae and 5 to 10 parts of herba erigerontis. The invention also provides a preparation method of the medicinal preparation of the gastrointestinal color ultrasound contrast agent. The medicinal preparation of the gastrointestinal color ultrasound contrast agent, disclosed by the invention, is safe in use, has no pain, no trauma, no toxicity and no anaphylactic reaction, and is short in inspection time, high in development rate, convenient to use and low in cost, a novel technology and a novel method are provided for early correct diagnosis of diseases, powerful basis is provided for clinical diagnosis, the gastrointestinal color ultrasound contrast agent is relatively ideal novel contrast agent, and a wide application prospect is obtained.

The invention relates to heart protecting and meridian dredging granules, and belongs to the field of Chinese medicaments. The granules comprise the following Chinese medicinal herbs by weight: 12 to 30 grams of notoginseng, 15 to 30 grams of root of red-rooted salvia, 20 to 60 grams of astragalus root, 10 to 15 grams of peach kernel, 10 to 20 grams of safflower, 15 to 30 grams of pilose asiabell root, 10 to 20 grams of arisaema cum bile, 10 to 20 grams of fructus aurantii, 10 to 20 grams of platycodon grandiflorum, 15 to 30 grams of earthworm, 20 to 30 grams of roasted coix seed, 20 to 30 grams of houttuynia, 20 to 30 grams of roasted bighead atractylodes rhizome, and 10 to 30 grams of roasted jujube kernel. The granules have the effects of calming endogenous wind, purging intense heat, strengthening spleen, removing dampness, resolving phlegm, promoting blood circulation to remove blood stasis, promoting qi circulation, nourishing blood and warming heart and pulse, can treat multiple heart diseases, are beneficial to definite diagnosis and definite treatment, are reliable in effect and easy to take, do not have toxic or side effect, treat both symptoms and root causes of the severe and lingering cardiovascular diseases, and have a remarkable effect.

The invention relates to application of an IL-8 positive initial T cell as a target for diagnosing thymus space-occupying diseases. The invention reveals that the IL-8 positive initial T cell in peripheral blood has significant meaning for diagnosis or typing of thymus space-occupying diseases, and can assist in diagnosis of thoracic adenoma by analyzing the proportion and function of the IL-8 positive initial T cell migrated from thymus in peripheral blood. According to the technical scheme, the accuracy of diagnosis or typing of thymus space-occupying diseases can be remarkably improved.

The invention discloses a urine protein marker for malignant hypertensive renal injury and a diagnostic application thereof. Specifically, the invention discloses the application of an identificationreagent for proteins selected from the following: a complement factor D, pancreatic ribonuclease, pancreatic stone protein-1-alpha, retinol conjugated protein 4, aggregin and a combination thereof, inpreparation of reagents for diagnosis of the malignant hypertensive renal injury of subjects. Herein, the protein marker has good clinical application prospects in the diagnosis of the malignant hypertensive renal injury.

The invention relates to a method for detecting a malfunction in a camshaft offset device of a motor vehicle. The main characteristic of a method according to the invention is that it comprises the following steps: a step of checking the standard engine operation conditions; a step of identifying a diagnosis area (3, 5) corresponding to a transient phase affecting a given period; and a step of detecting a malfunction of the offset device in said diagnosis area (3, 5).